C2I is very happy for our graduates and we wish them inspiration, success, and new scientific breakthroughs.

Gradiant delivers solutions that help to make a positive impact on both the economy and the environment. Their core focus is on solving the most complex water and wastewater challenges with innovative, sustainable solutions.

Frequency Therapeutics is a platform technology with an initial focus on chronic hearing loss, a potential $10B+ US market with no effective therapeutic solution. Other potential applications include gastrointestinal diseases and diabetes.

SciFluor Life Sciences is a drug discovery company applying expertise in fluorine chemistry to create a portfolio of differentiated best-in-class therapeutics.

Nano-C started operations in 2001, and is a leader in the world of nano-structured carbon materials and chemicals.

SQZ Biotech is a company founded out of the Massachusetts Institute of Technology (MIT). At SQZ, they have developed a high-throughput platform - CellSqueeze - for simple and effective material delivery into cells.

Ankaa Therapeutics is a leader in developing targeted small molecule drugs for personalized therapy.

Snapdragon Chemistry is headquartered in Boston, MA and is a leading provider of flow chemistry solutions and services.

Rilas Technologies provides services in the areas of purification of small molecule drug candidates from early discovery through to clinical phases.

Mercury Therapeutics Inc is a biotechnology company based out of 2 Gill St, Woburn, Massachusetts, United States.

The Augusta founding laboratories have used cutting edge genetic technologies and shRNA screening methodologies to uncover the ROS receptor tyrosine kinase as a cancer survival gene.

Veraquel has developed a transformative technology for the synthesis of peptide drugs, applicable from discovery to large-scale manufacturing by enabling the parallel synthesis of purified peptides.

Aquilus Pharmaceuticals is a privately held biotechnology company specializing in the treatment and management of pain.

At RootPath Genomics, Inc., we have developed a number of proprietary technologies in molecular engineering and computational biology that promise to bring precision medicine to immunotherapy of cancer.

Material Answers LLC specializes in conceptualization and development of innovative polymer material systems for achieving focused performance targets. Material Answers also provides consulting and expert witness services in material science and engineering and chemical engineering.